Spineway

Spineway FCF Growth

The Year-over-Year Free Cash Flow Growth of Spineway (ALSPW.PA) as of Nov 2, 2026 is 100.00 %. In the previous year, Year-over-Year Free Cash Flow Growth was 10.18 % — a change of 882.48% (higher).

FCF Growth

100.00 %

YoY

882.48%

Last updated:

Year-over-Year Free Cash Flow Growth of Spineway is 2025 100.00 % . Year-over-Year Free Cash Flow Growth of Spineway was 2024 10.18 % . It decreases by 882.48% higher compared to the previous year.

The Spineway FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2018
-129.06 EUR
Jan 1, 2019
-43.88 EUR
Jan 1, 2020
78.21 EUR
Jan 1, 2021
-107.34 EUR
Jan 1, 2022
-382.40 EUR
Jan 1, 2023
47.53 EUR
Jan 1, 2024
10.18 EUR
Jan 1, 2025
100.00 EUR
The Spineway FCF Growth history
YEARFCF GrowthYoY
100.00 %+882.48%
10.18 %-78.58%
47.53 %-112.43%
-382.40 %+256.24%
-107.34 %-237.25%
78.21 %-278.22%
-43.88 %-66.00%
-129.06 %+28.79%
-100.21 %+267.43%
-27.27 %-138.60%
70.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Spineway Stock analysis

What does Spineway do? Spineway SA, listed on the Paris Stock Exchange under the ticker ALSPW.PA, is a healthcare company based in Ecully, France. The company, which went public on February 8, 2013, focuses on the design, production, and sale of spinal column implants and surgical instruments. Spineway employs 35 full-time staff and operates within the healthcare sector, specifically in the health care industry. The company's product portfolio includes spinal systems, cervical and lumbar cages, cervical plates, and bone substitutes. Spineway SA is headquartered in the Auvergne-Rhône-Alpes region, reflecting its local presence in a key French economic area. The company's website is www.spineway.com, providing access to further information about its operations and offerings. Spineway SA has not reported any acquisitions, specific founding year, or additional details beyond its current operational scope and employee count. The company's activities are centered on medical devices for spinal care, targeting healthcare providers and surgical professionals. Spineway is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spineway stock

Year-over-Year Free Cash Flow Growth of Spineway is 100.00 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Spineway since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Spineway historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Spineway

All Key Metrics — Spineway